Your browser doesn't support javascript.
The potential role of resveratrol as supportive antiviral in treating conditions such as COVID-19 - A formulator's perspective.
van Brummelen, Roy; van Brummelen, Anna C.
  • van Brummelen R; vBC Consultants, Pretoria, South Africa. Electronic address: royvbc@gmail.com.
  • van Brummelen AC; vBC Consultants, Pretoria, South Africa.
Biomed Pharmacother ; 148: 112767, 2022 Apr.
Article in English | MEDLINE | ID: covidwho-1712467
ABSTRACT
With an increased transmissibility but milder form of disease of the omicron variant of COVID-19 and the newer antivirals often still out of reach of many populations, a refocus of the current treatment regimens is required. Safe, affordable, and available adjuvant treatments should also be considered and known drugs and substances need to be repurposed and tested. Resveratrol, a well-known antioxidant of natural origin, shown to act as an antiviral as well as playing a role in immune stimulation, down regulation of the pro-inflammatory cytokine release and reducing lung injury by reducing oxidative stress, is such an option. New initiatives and collaborations will however need to be found to unleash resveratrol's full potential in the pharmaceutical market.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Resveratrol / SARS-CoV-2 / COVID-19 / Antioxidants Topics: Variants Limits: Humans Language: English Journal: Biomed Pharmacother Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Resveratrol / SARS-CoV-2 / COVID-19 / Antioxidants Topics: Variants Limits: Humans Language: English Journal: Biomed Pharmacother Year: 2022 Document Type: Article